| Cat. No. |
Product Name |
Information |
| PC-21724 |
L6H21
MD-2 inhibitor
|
L6H21 is an orally active, potent and specific myeloid differentiation 2 (MD-2) inhibitor with binding KD value of 33.3 uM, blocks the formation of the LPS-TLR4/MD-2 complex. |
| PC-21705 |
KVS0001
SMG1 inhibitor
|
KVS0001 is a specific and bioavailable small molecule inhibitor of SMG1 kinase, disrupts nonsense mediated decay (NMD). |
| PC-21701 |
SKOG102
OLIG2 inhibitor
|
SKOG102 is a specific, brain penetrant small molecule inhibitor of protein transcription factor OLIG2 with IC50 of 1.04 uM, impacts OLIG2 DNA binding ability, inhibits human GBM4 and GBM8 cells with IC50 of 1-2 uM. |
| PC-21683 |
AJ2-30
SLC15A4 inhibitor
|
AJ2-30 is a specific small molecule SLC15A4 inhibitor with IFN-α suppression IC50 of 1.8 µM and MDP transport inhibition IC50 of 2.6 µM. |
| PC-21665 |
VY-3-249
ACSS2 inhibitor
|
VY-3-249 is a a potent Acetyl-CoA synthetase 2 (ACSS2) inhibitor with IC50 of 1.2 uM in in vitro biochemical TranScreener assays. |
| PC-21664 |
AD-8007
ACSS2 inhibitor
|
AD-8007 is a potent, brain permeable human Acetyl-CoA synthetase 2 (ACSS2) inhibitor with IC50 of 0.89 uM, a key metabolic enzyme involved in regulating fatty acid synthesis and protein acetylation in tumor cells. |
| PC-21663 |
AD-5584
ACSS2 inhibitor
|
AD-5584 is a potent, brain permeable human Acetyl-CoA synthetase 2 (ACSS2) inhibitor with IC50 of 0.86 uM, a key metabolic enzyme involved in regulating fatty acid synthesis and protein acetylation in tumor cells. |
| PC-21630 |
QP5038
QPCTL inhibitor
|
QP5038 is a potent inhibitor of glutaminyl-peptide cyclotransferase-like protein (QPCTL) with IC50 of 3.8 nM, shows promising in vitro and in vivo anti-tumor efficacies. |
| PC-21628 |
RBS-10
NQO1 inhibitor
|
RBS-10 is a small molecule that shows preferential cytotoxicity against cells pan-resistant to degraders, acts as a prodrug bioactivated by the oxidoreductase enzyme NQO1. |
| PC-21626 |
PQ912
Glutaminyl cyclase inhibitor
|
Varoglutamstat (PQ912) is a potent glutaminyl cyclase (QC) inhibitor with Ki values of 20-65 nM for human, rat, and mouse QC activity. |
| PC-21625 |
BK697
FIRΔexon2 inhibitor
|
BK697 is a small molecule targeting FIRΔexon2, potentially interacts with FIRΔexon2, significantly suppresses the FIRΔexon2 expression and inhibits tumor cell growth and several rRNA expressions. |
| PC-21576 |
PCC0105003
MARK inhibitor
|
PCC0105003 is a small molecule microtubule affinity-regulating kinases (MARKs) inhibitor with IC50 of 3.0, 2.0, 2.67 and 2.67 nM for MARK1, 2, 3 and 4 repectively. |
